Unio Capital LLC increased its position in shares of The Cigna Group (NYSE:CI - Free Report) by 93.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,453 shares of the health services provider's stock after purchasing an additional 45,989 shares during the period. The Cigna Group accounts for approximately 9.4% of Unio Capital LLC's portfolio, making the stock its 2nd largest position. Unio Capital LLC's holdings in The Cigna Group were worth $26,358,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in the business. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $25,000. Collier Financial acquired a new position in The Cigna Group during the fourth quarter worth about $32,000. Compagnie Lombard Odier SCmA acquired a new position in The Cigna Group during the fourth quarter worth $37,000. Transce3nd LLC purchased a new stake in shares of The Cigna Group in the 4th quarter worth about $38,000. Finally, Heck Capital Advisors LLC acquired a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $53,000. Hedge funds and other institutional investors own 86.99% of the company's stock.
The Cigna Group Stock Up 0.2%
NYSE CI opened at $321.70 on Tuesday. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The business has a 50 day moving average price of $325.22 and a two-hundred day moving average price of $309.91. The stock has a market cap of $85.94 billion, a PE ratio of 26.28, a P/E/G ratio of 0.98 and a beta of 0.47.
The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business's revenue was up 14.4% on a year-over-year basis. During the same period last year, the business earned $6.47 EPS. As a group, sell-side analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.
The Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be paid a $1.51 dividend. The ex-dividend date is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.88%. The Cigna Group's dividend payout ratio (DPR) is presently 33.44%.
Analysts Set New Price Targets
A number of analysts recently issued reports on the stock. Cowen restated a "buy" rating on shares of The Cigna Group in a research report on Monday, May 5th. Truist Financial raised their price objective on The Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Morgan Stanley upped their target price on The Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Cantor Fitzgerald increased their target price on The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research report on Thursday, March 20th. Finally, Royal Bank of Canada set a $355.00 price target on The Cigna Group in a report on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat, The Cigna Group currently has a consensus rating of "Buy" and a consensus price target of $379.33.
Check Out Our Latest Report on The Cigna Group
Insider Activity at The Cigna Group
In related news, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares in the company, valued at $4,289,920. This trade represents a 42.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. This represents a 14.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock valued at $13,603,991 over the last ninety days. Corporate insiders own 0.70% of the company's stock.
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.